Skip to main content
OpenTrials

Clinical trial condition

Advanced Malignancies

Explore clinical trials studying Advanced Malignancies. Study availability and eligibility vary by location and protocol.

59 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Advanced Malignancies trial results

Completed

A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors

NCT02923349

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Malignancies, +45 more
Locations
  • Rutgers, The State University of New Jersey New Brunswick, New Jersey, United States
  • New York University Clinical Cancer Center New York, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

NCT03126110

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +82 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University - Siteman Cancer Center St Louis, Missouri, United States
View all 38 locations
View Trial Details
Completed

Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies

NCT05391022

Conditions
Advanced Malignancies, Hematologic Diseases, Hematologic Neoplasms, +5 more
Locations
  • Gabrail Cancer Center Research Canton, Ohio, United States
  • Gettysburg Cancer Center Gettysburg, Pennsylvania, United States
  • Start Mountain Region West Valley City, Utah, United States
  • Hight Technology Hospital Medcenter Batumi, Georgia
View Trial Details
Completed

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

NCT04537715

Conditions
Adenoma, Advanced Malignancies, All Malignancies, +32 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. (cCARE) Encinitas, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Northwestern University-Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

NCT03474640

Conditions
Adenocarcinoma, Advanced Malignancies, Carcinoma, +28 more
Locations
  • Sarcoma Oncology Research Center Santa Monica, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • University of Miami Hospital Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 14 locations
View Trial Details
Completed

A Study of SHR-1501 Combined With SHR-1316 in Patients With Advanced Tumors

NCT03995472

Conditions
Advanced Malignancies
Locations
  • Sydney Southwest Private Hospital Liverpool, New South Wales, Australia
  • Scientia Clinical Research Randwick, New South Wales, Australia
  • Icon Cancer Centre South Brisbane South Brisbane, Queensland, Australia
  • John Flynn Private Hospital Tugun, Queensland, Australia
View Trial Details

Related conditions